Novartis (NVS)

• Market cap: $237B
• 1 day: -0.25%
• 5 days: -3.96%
• 1 month: -1.24%
• 3 months: 5.21%
• 6 months: 9.13%
• Year to date: 26.08%
• 1 year: 5.85%
• 5 years: 34.63%
• 10 years: 39.52%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Employees: 75,883

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

61% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 72

14% more funds holding in top 10

Funds holding in top 10: 14 [Q1] → 16 (+2) [Q2]

1% more funds holding

Funds holding: 1,338 [Q1] → 1,354 (+16) [Q2]

4% more repeat investments, than reductions

Existing positions increased: 487 | Existing positions reduced: 468

3% more capital invested

Capital invested by funds: $15.4B [Q1] → $15.9B (+$500M) [Q2]

0.37% less ownership

Funds ownership: 6.58% [Q1] → 6.21% (-0.37%) [Q2]

19% less call options, than puts

Call options by funds: $269M | Put options by funds: $331M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $118
• Avg. target: $118
• High target: $118

1 analyst rating

• positive: 0 0%
• neutral: 0 0%
• negative: 1 100%

Goldman Sachs James Quigley

$118

Sell Downgraded

12 Sep 2025